Clinical Trials Directory

Trials / Unknown

UnknownNCT06329843

Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Picterus AS · Industry
Sex
All
Age
12 Hours – 192 Hours
Healthy volunteers
Accepted

Summary

The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.

Detailed description

The purpose of this study is to compare serum bilirubin levels with non-invasive bilirubin measurements in neonates during the first 12 to 192 hours of life using the "Picterus Jaundice Pro" smartphone application with a proprietary calibration card placed over the neonate's sternum. We will also validate the accuracy of Picterus Jaundice Pro bilirubin measurements before and after phototherapy treatment.

Conditions

Interventions

TypeNameDescription
DEVICEPicterus Jaundice Pro (JP)Picterus Jaundice Pro photos will be obtained of enrolled subjects each time the patient has a serum bilirubin level obtained. Up to five paired measurements will be obtained per enrolled subject. The study nurse will place the proprietary calibration card over the subject's sternum and take six Picterus Jaundice Pro photos using a study iPhone within one hour of the serum bilirubin draw. This process takes less than one minute. After the study photos are obtained, the study nurse will record the serum and Picterus Jaundice Pro values in the data-recording log. In the event an enrolled infant requires phototherapy, a light occlusive adhesive patch will be placed over the center of the chest before phototherapy initiation. When a serum bilirubin level is obtained, the research nurse will remove the patch for a brief moment to take Picterus Jaundice Pro pictures (within one hour of the serum value draw).

Timeline

Start date
2024-02-12
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2024-03-26
Last updated
2024-03-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06329843. Inclusion in this directory is not an endorsement.